Summary of Product Characteristics
last updated on the eMC:
08/05/2009
When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.
Updated on 08/05/2009 and displayed until Current
|
Reasons for adding or updating:
|
-
Change to section 8 - MARKETING AUTHORISATION NUMBER(S)
-
Change to section 10 date of revision of the text
|
| Date of revision of text on the SPC: 19-Mar-2009 |
| Legal Category: GSL |
| Black Triangle (CHM):
NO |
Free-text change information supplied by the pharmaceutical company
|
| Change to the marketing authorisation number
|
|
Updated on 08/08/2007 and displayed until 08/05/2009
|
Reasons for adding or updating:
|
-
Change to section 7 - Marketing Authorisation Holder
-
Change to section 10 date of revision of the text
|
| Date of revision of text on the SPC: 03/2007 |
| Legal Category: POM |
| Black Triangle (CHM):
NO |
Free-text change information supplied by the pharmaceutical company
|
| Section 7 marketing authorsation holder - changed to sanofi-aventis
|
|
Updated on 25/07/2006 and displayed until 08/08/2007
|
Reasons for adding or updating:
|
-
Correction of spelling/typing errors
|
|
Updated on 19/09/2005 and displayed until 25/07/2006
|
Reasons for adding or updating:
|
-
Change to section 10 (date of (partial) revision of the text
|
|
Updated on 24/08/2001 and displayed until 19/09/2005
|
Reasons for adding or updating:
|
-
Transferred from eMC version 1
|
|
Updated on 16/10/2000 and displayed until 24/08/2001
|
Reasons for adding or updating:
|
|
|
|
Updated on 27/09/2000 and displayed until 16/10/2000
|
Reasons for adding or updating:
|
|
|
|
